Letter to Editor on: “Trends and Racial/Ethnic Disparities in Pharmacologic and Surgical Management of Treated Female Patients With Urinary Incontinence”

This letter to the editor comments on the recent study by Almadfaa et al. examining trends and racial and ethnic disparities in pharmacologic and surgical management of urinary incontinence among women in the United States. While the study provides important real-world evidence describing temporal changes in treatment patterns and highlighting potential inequities in care, several methodological limitations may influence interpretation of the findings. Notably, the analysis does not adjust for key socioeconomic factors, including insurance status, income, education, and healthcare access, which may confound observed racial and ethnic differences in treatment utilization. In addition, the absence of stratification by urinary incontinence severity and symptom burden limits the ability to determine whether differences in treatment reflect true disparities or variation in clinical presentation. The study's restriction to women receiving pharmacologic or surgical treatment introduces potential selection bias by excluding untreated individuals who may experience barriers to care. Furthermore, the lack of longitudinal outcome assessment, including symptom improvement, treatment adherence, recurrence, and complications, limits understanding of whether observed differences in care translate into meaningful differences in clinical outcomes and quality of life. Addressing these methodological concerns through incorporation of socioeconomic adjustment, severity stratification, inclusion of untreated populations, and longitudinal outcome evaluation will be essential to better define the drivers and consequences of disparities in urinary incontinence management. Such improvements would strengthen the evidence base and support more equitable, patient-centered care.